SCHEMBL23176397

SCHEMBL23176397

Nc1nc2c(ncn2C2OC(COP(=O)(O)OP(=O)(O)O)C(OP(=O)(O)OP(=O)(O)O)C2O)c(=O)[nH]1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 1/20 0.70
FUT5 Q11128 1/20 0.67
NT5E P21589 1/20 0.65
KRAS P01116 3/20 0.64
RNASEL Q05823 4/20 0.61
ENPP1 P22413 2/20 0.61
P2RY1 P47900 2/20 0.61
P2RY12 Q9H244 1/20 0.61
P2RY6 Q15077 2/20 0.60
P2RX3 P56373 2/20 0.60
P2RX1 P51575 1/20 0.60
P2RY11 Q96G91 1/20 0.60
P2RX4 Q99571 1/20 0.60
P2RY2 P41231 1/20 0.60
P2RY4 P51582 1/20 0.60
POLB P06746 1/20 0.57
DCPS Q96C86 1/20 0.57
IMPDH2 P12268 2/20 0.56
IMPDH1 P20839 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21067995 1.00 TGM2 (0.70) TGM2FUT5NT5EKRASRNASEL
SCHEMBL234673 1.00 TGM2 (0.70) TGM2FUT5NT5EKRASRNASEL
SCHEMBL877839 1.00 TGM2 (0.70) TGM2FUT5NT5EKRASRNASEL
SCHEMBL21256201 1.00 TGM2 (0.70) TGM2FUT5NT5EKRASRNASEL
SCHEMBL4011876 0.99 TGM2 (0.69) TGM2FUT5NT5EKRASRNASEL
SCHEMBL1533923 0.99 TGM2 (0.69) TGM2FUT5NT5EKRASRNASEL
SCHEMBL6512071 0.99 TGM2 (0.69) TGM2FUT5NT5EKRASRNASEL
SCHEMBL1533928 0.99 TGM2 (0.69) TGM2FUT5NT5EKRASRNASEL
SCHEMBL25567646 0.99 TGM2 (0.69) TGM2FUT5NT5EKRASRNASEL
SCHEMBL29355115 0.97 TGM2 (0.65) TGM2FUT5NT5EKRASRNASEL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 375 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260128119-A1 SCREENING METHODS FOR ACINETOBACTER BAUMANNII SPOT ENZYME MODULATORS Université Libre de Bruxelles (BE) 2026-05-07 US claimed
EP-4716528-A1 PREPARATION OF TOLERIZING NANOPARTICLES FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS Cour Pharmaceuticals Development Company Inc. (US) 2026-04-01 EP claimed
EP-4696775-A1 NOVEL VARIANT OF (P)PPGPP SYNTHETASE AND METHOD FOR PRODUCING 5?-INOSINIC ACID USING SAME Daesang Corporation (KR) 2026-02-18 EP claimed
EP-4677075-A2 TARGETING CELLS IN STRESSED GROWING CONDITIONS SNIPR Biome ApS (DK) 2026-01-14 EP claimed
WO-2025231164-A2 ENGINEERED PLANT MICROORGANISMS FOR RNAi DELIVERY AND USES THEREOF ROBIGO, INC. (US) 2025-11-06 WO claimed
EP-4605090-A1 SCREENING METHODS FOR ACINETOBACTER BAUMANNII SPOT ENZYME MODULATORS Université Libre de Bruxelles (BE) 2025-08-27 EP claimed
CN-118360353-B Method for improving thaxtomin A yield through Streptomyces scab relA gene 安徽农业大学 2025-04-08 CN claimed
EP-4477737-A1 THE METHOD OF OBTAINING AND EXTRACTION OF SECONDARY FUNGAL METABOLITES Uniwersytet Mikolaja Kopernika W Toruniu (PL) 2024-12-18 EP claimed
WO-2024243410-A1 PREPARATION OF TOLERIZING NANOPARTICLES FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS COUR PHARMACEUTICALS DEVELOPMENT COMPANY INC. (US) 2024-11-28 WO claimed
WO-2024214881-A1 NOVEL VARIANT OF (P)PPGPP SYNTHETASE AND METHOD FOR PRODUCING 5'-INOSINIC ACID USING SAME 대상 주식회사 2024-10-17 WO claimed
CN-115916981-A Salmonella strain for treating cancer and application thereof 全南国立大学校产学协力团 2023-04-04 CN claimed
CN-115717120-A Controllable growth engineering bacterium and construction method and application thereof 湖南大学 2023-02-28 CN claimed
EP-4128250-A1 REL/RELA/SPOT SMALL MOLECULES MODULATORS AND SCREENING METHODS Université Libre de Bruxelles (BE) 2023-02-08 EP claimed
CN-115349015-A Agents and methods for regulating sleep 北京大学 2022-11-15 CN claimed
WO-2022231043-A1 ATTENUATED SALMONELLA GALLINARUM STRAIN AND USE THEREOF 전남대학교산학협력단 2022-11-03 WO claimed
EP-4053283-A1 TUMOR-TARGETING SALMONELLA GALLINARUM STRAIN AND USE THEREOF Industry Foundation of Chonnam National University (KR) 2022-09-07 EP claimed
EP-4019624-A1 GENETICALLY ENGINEERED STRAIN HAVING HIGH-YIELD OF L-VALINE AND METHOD FOR PRODUCING L-VALINE BY FERMENTATION Tianjin University of Science & Technology (CN) 2022-06-29 EP claimed
EP-3414332-B1 IMPROVEMENT OF PHOTOSYNTHETIC ORGANISMS THROUGH THE MODULATION OF GUANOSINE TETRAPHOSPHATE HOMEOSTATIS CENTRE NAT RECH SCIENT (FR) 2022-06-29 EP claimed
WO-2022092887-A1 COMPOSITION FOR TARGETING CANCER CELL, COMPRISING STRAIN EXPRESSING MONOMERIC STREPTAVIDIN, AND BIOTINYLATED COMPOUND 전남대학교 산학협력단 2022-05-05 WO claimed
CN-114324540-A Guanosine tetraphosphate electrochemical type nano enzyme sensor and preparation method thereof 天津商业大学 2022-04-12 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260128119-A1 SCREENING METHODS FOR ACINETOBACTER BAUMANNII SPOT ENZYME MODULATORS STUB1, PPME1, BPGM TGM2 938/4885FUT5 3825/4885NT5E 2350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.